» Authors » Jeremy S Brown

Jeremy S Brown

Explore the profile of Jeremy S Brown including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 123
Citations 3270
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gates C, Brazel E, Kennedy E, Brown J, Ercoli G, Davies J, et al.
Vaccine . 2025 Mar; 54:126982. PMID: 40048932
Streptococcus pneumoniae is one of the world's foremost bacterial pathogens, with extensive serotype diversity that impacted the efficacy of current vaccines. Our group have previously reported the generation of a...
2.
Alfahl Z, Einarsson G, Elborn J, Gilpin D, ONeill K, Ferguson K, et al.
Respir Med . 2024 Dec; 236():107906. PMID: 39643125
Background And Objective: This study explored the relationship between total bacterial density, airway microbiota composition and clinical parameters in bronchiectasis. We determined changes with time during clinical stability and following...
3.
Gil E, Hatcher J, Saram S, Guy R, Lamagni T, Brown J
Future Microbiol . 2024 Nov; 20(2):163-177. PMID: 39552595
is an oral commensal organism belonging to the group (SAG). causes periodontitis as well as invasive, pyogenic infection of the central nervous system, pleural space or liver. Compared with other...
4.
Elneima O, McAuley H, Leavy O, Chalmers J, Horsley A, Ho L, et al.
Int J Epidemiol . 2024 Oct; 53(1). PMID: 39429158
No abstract available.
5.
Ramos-Sevillano E, Ercoli G, Betts M, Guerra-Assuncao J, Iverson A, Frank M, et al.
mBio . 2024 Oct; 15(11):e0175824. PMID: 39422467
Virulence screens have indicated potential roles during infection for the one-carbon metabolism pathway component Fhs and proline synthesis mediated by ProABC. To define how these metabolic pathways affect virulence, we...
6.
Ercoli G, Selway-Clarke H, Truijen D, Folkmanaite M, Oulton T, Norris-Grey C, et al.
Clin Transl Immunology . 2024 Oct; 13(10):e70012. PMID: 39416767
Objectives: Patients with rheumatoid arthritis (RA) have an increased susceptibility to infections, including those caused by . Why RA is associated with increased susceptibility to is poorly understood. This study...
7.
Leavy O, Russell R, Harrison E, Lone N, Kerr S, Docherty A, et al.
ERJ Open Res . 2024 Oct; 10(5). PMID: 39351379
Background: In patients with coronavirus disease 2019 (COVID-19) requiring supplemental oxygen, dexamethasone reduces acute severity and improves survival, but longer-term effects are unknown. We hypothesised that systemic corticosteroid administration during...
8.
Brown J
Eur Respir J . 2024 Aug; 64(2). PMID: 39147424
No abstract available.
9.
Elneima O, Hurst J, Echevarria C, Quint J, Walker S, Siddiqui S, et al.
ERJ Open Res . 2024 Jul; 10(4). PMID: 39010888
Background: The long-term outcomes of COVID-19 hospitalisation in individuals with pre-existing airway diseases are unknown. Methods: Adult participants hospitalised for confirmed or clinically suspected COVID-19 and discharged between 5 March...
10.
Mehta P, Sanz-Magallon Duque de Estrada B, Denneny E, Foster K, Turner C, Mayer A, et al.
Front Immunol . 2024 Jun; 15:1372658. PMID: 38827740
Background: Persistent radiological lung abnormalities are evident in many survivors of acute coronavirus disease 2019 (COVID-19). Consolidation and ground glass opacities are interpreted to indicate subacute inflammation whereas reticulation is...